Uncertainty in Accounting Estimates Due to COVID-19
First written in FY2020. 3 of 7 entries say "Reframed", first in FY2021. Latest entry: FY2024-Q3.
Planet moved to the "Worse" side of this theme in 2021, 1 year before the typical company in this theme (2022).
The whole theme swung hardest in 2026: 5 of 22 companies on the "Worse" side.
102 other companies' latest entry also says "Restated".
- FY2024-Q3RestatedAnnual report
「During the cumulative third-quarter period, there were no new matters relating to the business or financial conditions described in this quarterly report that could materially affect investors' decisions, and no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The Company states that there have been no significant changes in the risks related to its business and other matters, including uncertainty in accounting estimates resulting from the novel coronavirus disease. - FY2024-Q2RestatedAnnual report
「During the cumulative second-quarter period, there were no new matters relating to the business or financial conditions described in this quarterly report that could materially affect investors' decisions, and no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The Company states that there have been no significant changes in the risks related to its business and other matters, including uncertainty in accounting estimates resulting from the novel coronavirus disease. - FY2024-Q1RestatedAnnual report
「During the cumulative first-quarter period, there were no new matters relating to the business or financial conditions described in this quarterly report that could materially affect investors' decisions, and no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The Company states that there have been no significant changes in the risks related to its business and other matters, including uncertainty in accounting estimates resulting from the novel coronavirus disease. - FY2023ReframedAnnual report
「Regarding the impact of COVID-19, the Company reflected accounting estimates in its accounting treatment on the assumption, based on information from external sources and other factors, that the impact would continue for a certain period during the fiscal year ending July 2024. The Company has determined that the impact of COVID-19 will not have a material impact on the assumptions underlying significant accounting estimates during the current fiscal year or thereafter, including the following fiscal year.」
While the period covered by the accounting assumption that the effects of infectious diseases will continue has been updated to the fiscal year ending July 2024, the Company has determined that there is no impact on significant estimates. - FY2022ReframedAnnual report
「Regarding the impact of the spread of COVID-19, the Company reflected accounting estimates in its accounting treatment on the assumption, based on information from external sources and other factors, that the impact would continue for a certain period during the fiscal year ending July 2023. The Company has determined that the spread of COVID-19 will not have a material impact on the assumptions underlying significant accounting estimates during the current fiscal year or thereafter, including the following fiscal year.」
The period covered by the assumption that the impact of the infectious disease would continue was updated from the fiscal year ending July 2022 to the fiscal year ending July 2023 and reflected in the accounting estimates. - FY2021ReframedAnnual report
「Regarding the impact of the spread of COVID-19, the Company reflected accounting estimates in its accounting treatment on the assumption, based on information from external sources and other factors, that the impact would continue for a certain period during the fiscal year ending July 2022. The Company has determined that the spread of COVID-19 will not have a material impact on the assumptions underlying significant accounting estimates during the current fiscal year or thereafter, including the following fiscal year.」
The Company states that it reflected in its accounting estimates the assumption that the impact of the infectious disease would continue for a certain period during the fiscal year ending July 2022. - FY2020First statedAnnual report
「However, the impact of the spread of COVID-19 remains subject to many uncertainties and could affect the Company's financial position and operating results in the following fiscal year.」
The potential impact of the infectious disease on the Company's financial position and operating results in the following fiscal year is disclosed as uncertainty related to accounting estimates.